• Skip to main content

Hearing Loss Treatment Report

www.HearingLossTreatmentReport.com

SPI-1005

New pill [SPI-1005] that may help improve age-related hearing loss by protecting delicate hair cells in the inner ear

February 8, 2021

https://www.dailymail.co.uk/health/article-9238361/New-pill-help-hear-clearly-protecting-delicate-hair-cells-inner-ear.html

New pill that may help improve age-related hearing loss by protecting delicate hair cells in the inner ear
A new drug, SPI-1005, aids hearing by protecting delicate hair cells in inner ear
It is also being tested in U.S. as a potential treatment for patients with Covid-19
The number of auditory hair cells declines due to age, disease and loud noise

Sound Pharmaceuticals announces positive topline results from SPI-1005 Phase 2b clinical trial… clinically relevant improvements in sensorineural hearing loss… 65% and 95% over placebo at 8 weeks…

June 25, 2019

https://finance.yahoo.com/news/sound-pharmaceuticals-announces-positive-topline-130000754.html

Sound Pharmaceuticals announces positive topline results from SPI-1005 Phase 2b clinical trial… clinically relevant improvements in sensorineural hearing loss… 65% over placebo at 8 weeks

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (PANIHL)

August 24, 2018

https://clinicaltrials.gov/ct2/show/NCT02779192

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (PANIHL)

Powered by Urgent Research

Copyright © 2025 Urgent Research